These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 8879118)
1. E7 proteins of four groups of human papillomaviruses, irrespective of their tissue tropism or cancer association, possess the ability to transactivate transcriptional promoters E2F site dependently. Hiraiwa A; Kiyono T; Suzuki S; Ohashi M; Ishibashi M Virus Genes; 1996; 12(1):27-35. PubMed ID: 8879118 [TBL] [Abstract][Full Text] [Related]
2. The relative ability of human papillomavirus type 6 and human papillomavirus type 16 E7 proteins to transactivate E2F-responsive elements is promoter- and cell-dependent. Armstrong DJ; Roman A Virology; 1997 Dec; 239(1):238-46. PubMed ID: 9426463 [TBL] [Abstract][Full Text] [Related]
3. E2F-Rb complexes assemble and inhibit cdc25A transcription in cervical carcinoma cells following repression of human papillomavirus oncogene expression. Wu L; Goodwin EC; Naeger LK; Vigo E; Galaktionov K; Helin K; DiMaio D Mol Cell Biol; 2000 Oct; 20(19):7059-67. PubMed ID: 10982822 [TBL] [Abstract][Full Text] [Related]
4. Regulation of the Cdc25A gene by the human papillomavirus Type 16 E7 oncogene. Katich SC; Zerfass-Thome K; Hoffmann I Oncogene; 2001 Feb; 20(5):543-50. PubMed ID: 11313986 [TBL] [Abstract][Full Text] [Related]
5. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways. Goodwin EC; DiMaio D Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078 [TBL] [Abstract][Full Text] [Related]
6. Papillomavirus E7 protein binding to the retinoblastoma protein is not required for viral induction of warts. Defeo-Jones D; Vuocolo GA; Haskell KM; Hanobik MG; Kiefer DM; McAvoy EM; Ivey-Hoyle M; Brandsma JL; Oliff A; Jones RE J Virol; 1993 Feb; 67(2):716-25. PubMed ID: 8380462 [TBL] [Abstract][Full Text] [Related]
7. Cell cycle-dependent disruption of E2F-p107 complexes by human papillomavirus type 16 E7. Zerfass K; Levy LM; Cremonesi C; Ciccolini F; Jansen-Dürr P; Crawford L; Ralston R; Tommasino M J Gen Virol; 1995 Jul; 76 ( Pt 7)():1815-20. PubMed ID: 9049387 [TBL] [Abstract][Full Text] [Related]
8. Protein domains governing interactions between E2F, the retinoblastoma gene product, and human papillomavirus type 16 E7 protein. Huang PS; Patrick DR; Edwards G; Goodhart PJ; Huber HE; Miles L; Garsky VM; Oliff A; Heimbrook DC Mol Cell Biol; 1993 Feb; 13(2):953-60. PubMed ID: 7678696 [TBL] [Abstract][Full Text] [Related]
9. Association of the human papillomavirus type 16 E7 protein with the S-phase-specific E2F-cyclin A complex. Arroyo M; Bagchi S; Raychaudhuri P Mol Cell Biol; 1993 Oct; 13(10):6537-46. PubMed ID: 8413252 [TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus type 16 E7 maintains elevated levels of the cdc25A tyrosine phosphatase during deregulation of cell cycle arrest. Nguyen DX; Westbrook TF; McCance DJ J Virol; 2002 Jan; 76(2):619-32. PubMed ID: 11752153 [TBL] [Abstract][Full Text] [Related]
12. Binding of the human E2F transcription factor to the retinoblastoma protein but not to cyclin A is abolished in HPV-16-immortalized cells. Pagano M; Dürst M; Joswig S; Draetta G; Jansen-Dürr P Oncogene; 1992 Sep; 7(9):1681-6. PubMed ID: 1323816 [TBL] [Abstract][Full Text] [Related]
13. Regulation of cyclin E gene expression by the human papillomavirus type 16 E7 oncoprotein. Vogt B; Zerfaß-Thome K; Schulze A; Botz JW; Zwerschke W; Jansen-Dürr P J Gen Virol; 1999 Aug; 80 ( Pt 8)():2103-2113. PubMed ID: 10466809 [TBL] [Abstract][Full Text] [Related]
14. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. Chellappan S; Kraus VB; Kroger B; Munger K; Howley PM; Phelps WC; Nevins JR Proc Natl Acad Sci U S A; 1992 May; 89(10):4549-53. PubMed ID: 1316611 [TBL] [Abstract][Full Text] [Related]
15. Disruption of the human papillomavirus type 16 E2 gene protects cervical carcinoma cells from E2F-induced apoptosis. Sanchez-Perez AM; Soriano S; Clarke AR; Gaston K J Gen Virol; 1997 Nov; 78 ( Pt 11)():3009-18. PubMed ID: 9367388 [TBL] [Abstract][Full Text] [Related]
16. Cell-type-specific separate regulation of the E6 and E7 promoters of human papillomavirus type 6a by the viral transcription factor E2. Rapp B; Pawellek A; Kraetzer F; Schaefer M; May C; Purdie K; Grassmann K; Iftner T J Virol; 1997 Sep; 71(9):6956-66. PubMed ID: 9261424 [TBL] [Abstract][Full Text] [Related]
17. Positive and negative regulation of cell proliferation by E2F-1: influence of protein level and human papillomavirus oncoproteins. Melillo RM; Helin K; Lowy DR; Schiller JT Mol Cell Biol; 1994 Dec; 14(12):8241-9. PubMed ID: 7969161 [TBL] [Abstract][Full Text] [Related]
19. E2F binding is required but not sufficient for repression of B-myb transcription in quiescent fibroblasts. Bennett JD; Farlie PG; Watson RJ Oncogene; 1996 Sep; 13(5):1073-82. PubMed ID: 8806697 [TBL] [Abstract][Full Text] [Related]
20. Anchorage-independent transcription of the cyclin A gene induced by the E7 oncoprotein of human papillomavirus type 16. Schulze A; Mannhardt B; Zerfass-Thome K; Zwerschke W; Jansen-Dürr P J Virol; 1998 Mar; 72(3):2323-34. PubMed ID: 9499093 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]